The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF)

The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF)

BackgroundBecause of the short half-life of non-vitamin K antagonist oral anticoagulants (NOACs), consistent drug adherence is crucial to maintain the effect of anticoagulants for stroke prevention in atrial fibrillation (AF). Considering the low adherence to NOACs in practice, we developed a mobile...

Full description

Bibliographic Details
Main Authors: Minjae Yoon, Jin Joo Park, Taeho Hur, Cam-Hao Hua, Chi Young Shim, Byung-Su Yoo, Hyun-Jai Cho, Seonhwa Lee, Hyue Mee Kim, Ji-Hyun Kim, Sungyoung Lee, Dong-Ju Choi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
NOAC
drug adherence
mobile application
mobile health
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130216/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130216/full

Similar Items